Videos | Dr Shaper Mirza

Videos

Capsule switching and the challenge of vaccine evasion: LUMS Dr Shaper Mirza

Streptococcus Pneumoniae is a shapeshifter, says Dr Shaper Mirza in her brilliant talk on 'Capsule switching, and the challenge of vaccine evasion: Current situation and future directions' delivered on day four of a weeklong special workshop for 22 bioinformaticians (from the NIH, Szabist, KU etc) from across Pakistan organised by the Aga Khan University Department of Paediatrics & Child Health, its Infectious Disease Research Lab and the CITRIC Centre for Bioinformatics and Computational Biology in Karachi, Pakistan.

Aug 3, 2025

Revolutionising Cancer Care: A Conversation with Dr. Azra Raza

In this inspiring conversation, Dr. Azra Raza, renowned oncologist and author of The First Cell, sits down with Dr. Shaper Mirza, Associate Professor at LUMS. Drawing from decades of research and her deep connection to Urdu poetry and literature, Dr. Raza shares her vision for revolutionising cancer treatment through early detection and compassionate care. This thought-provoking discussion transcends medicine, offering profound insights into healing and resilience.

Dec 1, 2024

The LUMS Podcast 2024 | MS and PhD programmes in Biology

Dr. Shaper Mirza, Associate Professor, Syed Babar Ali School of Science and Engineering, discusses the fascinating secrets of life sciences. Get first-hand insights about the MS and PhD programmes in Biology at LUMS, and learn about interdisciplinary learning and research, as well as the exciting career opportunities these programmes can unlock.

Jan 1, 2024

Monitoring COVID-19 with Dr. Shaper Mirza

Dr. Shaper Mirza and her team have recently been awarded 12 million rupees as a Rapid Research Grant by The World Bank and HEC, to conduct a study and dig out epidemiological patterns in how the human body responds to COVID-19 infection. The purpose is to help guide doctors and researchers for better clinical decision making for this disease. For this project, while local collaborators provide mathematical and computational modelling support, others contribute to patient recruitment, expertise and resources in viral culture and provision of access to demographic and anthropological data. Meanwhile, international partners from US and UK provide HLA typing of patients and consultation on immunological assays. This partnership will eventually help diffuse findings to inform policies for community surveillance of COVID-19.

Feb 1, 2023